title: Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.
authors.affiliation: a Hémato-Oncologie , AP-HP - Hôpital Saint-Louis (SLS) , Paris , France ;|b Université Paris Diderot, Sorbonne Paris Cité , Paris , France ;
authors.forename: Sandy
authors.initials: S
authors.lastname: Amorim
authors.affiliation: a Hémato-Oncologie , AP-HP - Hôpital Saint-Louis (SLS) , Paris , France ;
authors.forename: Isabelle
authors.initials: I
authors.lastname: Fleury
authors.affiliation: c CHU De l'Archet - Hemato-Oncologie , Nice , France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Mounier
authors.affiliation: a Hémato-Oncologie , AP-HP - Hôpital Saint-Louis (SLS) , Paris , France ;|b Université Paris Diderot, Sorbonne Paris Cité , Paris , France ;
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Harel
authors.affiliation: a Hémato-Oncologie , AP-HP - Hôpital Saint-Louis (SLS) , Paris , France ;
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
authors.affiliation: a Hémato-Oncologie , AP-HP - Hôpital Saint-Louis (SLS) , Paris , France ;|b Université Paris Diderot, Sorbonne Paris Cité , Paris , France ;
authors.forename: Catherine
authors.initials: C
authors.lastname: Thieblemont
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D060830:Consolidation Chemotherapy / Q000379:methods; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects; D016403:Lymphoma, Large B-Cell, Diffuse / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D012189:Retrospective Studies; D000069283:Rituximab / Q000008:administration & dosage*; D033581:Stem Cell Transplantation / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000069283:Rituximab; D005047:Etoposide; D008942:Mitoxantrone; D007069:Ifosfamide